Lasa Supergenerics Limited

LASA.NSNSEHealthcare

₹7.58Today1.56% · -₹0.12

Day rangeTrading above day high

₹0.00₹0.00

52W range

23% · ₹5.67–₹14.08

Open

₹0.00

Prev close

₹7.70

AskWarren SignalsUpdated 23:21 IST

Momentum Bearish(-1.56% today)Volume 25% Below Avg52W Position Mid-range

Volume

26.1K

25% below avg

Avg vol (20D)

34.8K

20-day baseline

Mkt cap

₹38.18Cr

Small Cap

P/E TTM

0.0×

Trade Lasa Supergenerics Limited with Artha

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Classification

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Stock ExchangeNSE

Identifiers

Ticker SymbolLASA.NS

Websitelasalabs.com

Company Info

HeadquartersNot available

Employees0

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account